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RESPONSE: NO MORE “28 DAYS AND YOU’RE CURED”
Allan J. Cohen, M.A., M.F.T.; William M. “Mel” Taylor, M.S.W.; and Claudette Wallace, M.A.
Mel Taylor: The naïve question politicians
and others ask is, “Why can’t they just quit?”
The answer is that addiction is a chronic
condition, and relapse is one of its behav-
ioral consequences.
Claudette Wallace: To see that alcoholism
and addiction are chronic diseases, you just
need to look at the high rate of recidivism.
Most of the people we work with make many
attempts and have many failures before they
get into ongoing recovery. And even then,
the minute they relapse or slip, they’re imme-
diately back where they started. 
Allan Cohen: The view that drug depend-
ence is a chronic disease has been implicit
in the way opioid addiction has been treated
for the past 40 or 50 years. Along with coun-
seling and other psycho-support services,
we give patients opioid agonist maintenance
therapy to normalize the brain chemistry
that opiates have disrupted.
I agree with this concept and approach.
At the same time, I’m not convinced that
everybody who starts abusing drugs imme-
diately has a chronic condition. The scien-
tific literature, especially current imaging
work, confirms that repeated drug expo-
sures produce organic, functional changes
to the brain that support continued use and
dependence, but this doesn’t happen all at
once. It’s a developmental process that occurs
over time. I think some of the patients we
see are in acute rather than chronic stages
of drug abuse, and we might prevent them
from developing dependence if we can diag-
nose them soon enough and treat them effec-
tively.
Wallace:Recovery, like addiction, is a process.
People learn something each time they fail
to stay sober. That doesn’t mean everyone
will succeed. Some people learn all they need
to know to maintain a lengthy abstinence
after one treatment episode; others take mul-
tiple episodes. Others may be neurologically
damaged so that they cannot sustain recov-
ery, even after many episodes. 
Cohen:People get tired of the revolving door
of going into treatment and then relapsing,
and going back into treatment and relaps-
ing again. At some point in time, something
occurs, something changes. They come to
a place where they’re more willing to tran-
sition into something other than what they’ve
been going through.
Wallace: That’s true. After several relapses,
people are tired and often feeling very
hopeless.
Cohen: At the same time, just saying “Some
people are more motivated” doesn’t come
close to explaining why some people do well
in treatment, and others don’t. We work
hard to help our clients create their own
relapse prevention plans and feel excited
about them. We know, though, that as soon
as they leave the program they will face chal-
lenges regarding housing, jobs, and fami-
lies. Along with drug addictions, many have
co-occurring psychiatric conditions, poor
living conditions, or medical conditions.
All these factors play important roles in the
recurrence and chronicity of addiction.
Taylor: As the authors indicate (Dennis and
Scott, 2007), comorbidity contributes to
both the frequency and severity of relapse.
Many people find it hardest to stay sober
when they are depressed. If they can keep
their mood up, sobriety tends to be more
stable and relapse less likely. Genetic factors
affect people’s drug histories too. I have read
 
that 20 to 25 percent of people who abuse
substances at a high level have family mem-
bers who do so as well. 
Behavioral health responses
Taylor:When we frame addiction as a chronic
disease, we begin to think in terms of a life-
long effort to control certain vulnerabilities.
“Managing” becomes the operative term—
as it is with other chronic conditions. There’s
no saying, “28 days, check out, and you’re
cured.”
Wallace:We talk to our clients about relapse
being part of the disease. I think that’s
very important. I don’t think we do it 
enough.
Cohen: Most programs make patients aware
that relapse is possible. Where I think we
fall short is in not taking a closer look at
what each individual patient’s relapses might
look like, what might trigger them, and what
to do if they come up. “Call your sponsor if
you feel like taking a drink” might work 
for some people, but this article is talking
about people with severe and persistent 
problems in their lives. Many are trying to
stay sober and clean for the first time in many
years. They need some sort of ongoing sup-
port structure. 
Wallace:The first thing I would undertake,
if my program, ChangePoint, were to receive
a windfall, would be to implement a relapse
prevention structure where clients would
keep coming back to talk about whatever
they’re struggling with. The program would
provide support and help them remember
and use the tools they learned in treatment.
In the best of all worlds, people would not
be simply invited to drop in—they would
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Cohen: Our predicament at present is that
when it comes to incorporating chronic dis-
ease models into treatment programs, we
don’t yet know what interventions really
work. The research results on long-term
monitoring and early reintervention are
mixed. To take one example, the Betty Ford
Center makes telephone followup for sev-
eral months part of its regular treatment.
The clients love to hear from the center, and
the center regards the calls as an indispen-
sable tool. However, when NIDA’s Clinical
Trials Network put telephone monitoring
to an empirical test, the data didn’t show
that it made much difference.
Wallace: As part of a methamphetamine
research project at ChangePoint, we called
clients periodically over 12 months to see
how they were doing. I have the impression
that the effect was very positive. Clients com-
mented that they waited for the phone to
ring and appreciated the fact that somebody
was checking with them. 
Cohen:In the 1960s, we had social workers
or case workers, and they handled every-
thing. We’re very specialized now, and episo-
dic in our approach. This article says, “Let’s
go back to being more comprehensive.”
Public health and systems responses
Taylor: When we start talking about addic-
tion as a chronic disease, I think we auto-
matically imply that there’s a need for a broad
public health approach. Several years ago,
some local doctors, working with us at the
Council on Alcohol and Drugs Houston,
reported that nearly 80 percent of admis-
sions to the county hospitals involved sub-
stance abuse problems. The message was: It
makes sense to provide more dollars for screen-
ing and assessment of these problems before
people show up at the emergency room.
Cohen: I believe screening and brief inter-
vention in primary care can help with a
chronic disease model much better than
complete reliance on isolated treatment pro-
grams that people have to find and access
to get help. When primary care physicians
can detect a chronic disease like substance
abuse and intervene or refer the patient to
a specialist, the impact is tremendous. We
wouldn’t see as many people needing to
return for residential or inpatient treatment. 
Taylor:Absolutely. We’ve been testing a pro-
tocol where a primary care physician iden-
tifies a possible substance abuse problem
and refers the patient to someone who does
a brief motivational interview. The inter-
view consists of a discussion around, “If you
keep drinking this way, you’re going to end
up with X, Y, or Z issue. Here’s some infor-
mation. I’d like to talk with you more about
it next time. Take care of yourself.” The study
has been going on for 5 years, and the results
are profound: More than 50 percent 
of the time, simply talking to the patient
leads to a reduction in substance use. One
factor that facilitates the program here in
Harris County is that we are co-located with
our physicians. 
Cohen: We’re starting to engage in some
of that same kind of work now in California.
I think it’s the wave of the future.
Taylor: The approach is exactly parallel to
the way we deal with other chronic diseases.
For example, take patients at risk for heart
attacks. The cardiologist knows that if the
patient doesn’t change his lifestyle, he’s going
to be back. So, the cardiologist works with
nutritionists, dietitians, exercise coaches,
and so on, who put the patients on a pro-
gram of behavioral change, and the heart
attack risk goes down.
Cohen: Implementing this approach won’t
be simple. For starters, do we put seasoned
and educated substance abuse staff in pri-
mary medical settings, or train the staff in
primary care settings?
Taylor: We were concerned initially that
physicians might not be willing to add sub-
stance abuse counseling and brief motiva-
tional interviewing to what they do. As it
turned out, they weren’t. However, they are
eager to have substance abuse counselors
and others on board alongside them, car-
rying out that work. I guarantee you, if we
said we’re pulling out, the physicians would
scream  and  holler. Pediatricians  and 
obstetrician-gynecologists are also partici-
pating to prevent fetal exposure to drugs.
What has been most exciting is these doc-
tors’ recognition that substance abuse pro-
fessionals can, indeed, pull our fair share as
part of a team that produces better outcomes
for patients.
Cohen: I agree wholeheartedly with the
authors’ recommendations for research, par-
ticularly on cost-effectiveness. With accred-
itation and funding being tied to the use of
evidence-based treatments, we need to show
both clinical results and cost-effectiveness
for whatever we implement.
Taylor: Investing in treating addiction as a
chronic problem makes economic sense and
public health sense. Demonstrating this fact
is the only way we’re going to see a funda-
mental change in policy. If you spend more
for a longer term, more comprehensive pro-
gram, you’re going to get a better return—
better recovery, less frequent relapse, and
perhaps less intense relapse. The bottom line
is that we can pay for it now, or we can
pay for it later, and we can’t afford to keep
paying for it later.
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